Comparison of escitalopram and citalopram efficacy: A meta-analysis (Q88082336)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24930412 AND SRC:MED&resulttype=core&format=json

20 March 2020

title

Comparison of escitalopram and citalopram efficacy: A meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24930412 AND SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

1 reference

Pascal Auquier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24930412 AND SRC:MED&resulttype=core&format=json

20 March 2020

Stéphane Robitail

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24930412 AND SRC:MED&resulttype=core&format=json

20 March 2020

Pierre-Michel Llorca

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24930412 AND SRC:MED&resulttype=core&format=json

20 March 2020

Benoît Rive

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24930412 AND SRC:MED&resulttype=core&format=json

20 March 2020

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24930412 AND SRC:MED&resulttype=core&format=json

International Journal of Psychiatry in Clinical Practice

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24930412 AND SRC:MED&resulttype=core&format=json

20 March 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24930412 AND SRC:MED&resulttype=core&format=json

20 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24930412 AND SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

259-268

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24930412 AND SRC:MED&resulttype=core&format=json

Escitalopram : a review of its use in the management of major depressive and anxiety disorders

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

Meta-analytic tools for medical decision making: a practical guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

Meta-analysis of psychotherapy outcome studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

The pharmacological effect of citalopram residues in the (S)-( )-enantiomer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

Escitalopram, the S-( )-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

Separate site(s) of action of optical isomers of 1-methyl-5-phenyl-5-propylbarbituric acid with opposite pharmacological activities at the GABA receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

Systematic review and guide to selection of selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/13651500310003408

10.1080/13651500310003408

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24930412 AND SRC:MED&resulttype=core&format=json

20 March 2020

1 reference